Truist analyst Tobey Sommer raised the firm’s price target on Huron (HURN) to $165 from $140 and keeps a Buy rating on the shares. The company’s healthcare and education offering remains robust as changes in regulatory policy from the Trump administration should lead to increased demand for its services, and the firm remains buyers of Huron Consulting Group after reporting upside results and FY25 guidance above consensus expectations, the analyst tells investors in a research note.